JP2013147511A5 - - Google Patents

Download PDF

Info

Publication number
JP2013147511A5
JP2013147511A5 JP2013097681A JP2013097681A JP2013147511A5 JP 2013147511 A5 JP2013147511 A5 JP 2013147511A5 JP 2013097681 A JP2013097681 A JP 2013097681A JP 2013097681 A JP2013097681 A JP 2013097681A JP 2013147511 A5 JP2013147511 A5 JP 2013147511A5
Authority
JP
Japan
Prior art keywords
use according
inflammation
meta arsenite
sodium meta
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013097681A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013147511A (ja
JP5825611B2 (ja
Filing date
Publication date
Priority claimed from US12/068,006 external-priority patent/US8945505B2/en
Application filed filed Critical
Publication of JP2013147511A publication Critical patent/JP2013147511A/ja
Publication of JP2013147511A5 publication Critical patent/JP2013147511A5/ja
Application granted granted Critical
Publication of JP5825611B2 publication Critical patent/JP5825611B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013097681A 2007-02-02 2013-05-07 痛みおよび炎症の処置のためのヒ素化合物の使用 Expired - Fee Related JP5825611B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US89900707P 2007-02-02 2007-02-02
US60/899,007 2007-02-02
US12/068,006 US8945505B2 (en) 2007-02-02 2008-01-31 Use of arsenic compounds for treatment of pain and inflammation
US12/068,006 2008-01-31

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2009548463A Division JP5411709B2 (ja) 2007-02-02 2008-02-01 痛みおよび炎症の処置のためのヒ素化合物の使用

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014209816A Division JP5853347B2 (ja) 2007-02-02 2014-10-14 痛みおよび炎症の処置のためのヒ素化合物の使用

Publications (3)

Publication Number Publication Date
JP2013147511A JP2013147511A (ja) 2013-08-01
JP2013147511A5 true JP2013147511A5 (enExample) 2013-12-12
JP5825611B2 JP5825611B2 (ja) 2015-12-02

Family

ID=39322911

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2009548463A Expired - Fee Related JP5411709B2 (ja) 2007-02-02 2008-02-01 痛みおよび炎症の処置のためのヒ素化合物の使用
JP2013097681A Expired - Fee Related JP5825611B2 (ja) 2007-02-02 2013-05-07 痛みおよび炎症の処置のためのヒ素化合物の使用
JP2014209816A Expired - Fee Related JP5853347B2 (ja) 2007-02-02 2014-10-14 痛みおよび炎症の処置のためのヒ素化合物の使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2009548463A Expired - Fee Related JP5411709B2 (ja) 2007-02-02 2008-02-01 痛みおよび炎症の処置のためのヒ素化合物の使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014209816A Expired - Fee Related JP5853347B2 (ja) 2007-02-02 2014-10-14 痛みおよび炎症の処置のためのヒ素化合物の使用

Country Status (18)

Country Link
US (2) US8945505B2 (enExample)
EP (1) EP2114419B8 (enExample)
JP (3) JP5411709B2 (enExample)
KR (1) KR101479519B1 (enExample)
CN (2) CN103550253A (enExample)
AR (1) AR065138A1 (enExample)
AU (1) AU2008214084C9 (enExample)
BR (1) BRPI0807154B8 (enExample)
CA (3) CA2845292C (enExample)
DK (1) DK2114419T3 (enExample)
ES (1) ES2460868T3 (enExample)
IL (3) IL200173A (enExample)
MX (1) MX2009008174A (enExample)
NZ (1) NZ578621A (enExample)
PL (1) PL2114419T3 (enExample)
RU (3) RU2630574C2 (enExample)
TW (1) TWI404538B (enExample)
WO (1) WO2008097824A2 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090061022A1 (en) * 2004-10-08 2009-03-05 Sang Bong Lee Pharmaceutical composition comprising arsenite for the treatment of malignancy
EP1721615A1 (en) 2005-05-09 2006-11-15 Komipharm International Co., Ltd. Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis
US8045505B2 (en) * 2007-01-18 2011-10-25 Science Applications International Corporation Mechanism for automatic network formation and medium access coordination
WO2009109911A1 (en) 2008-03-04 2009-09-11 Pfizer Limited Methods of treating chronic pain
EP2432480B1 (en) * 2009-05-18 2021-05-05 The University of Hong Kong Compositions and methods for treating inflammatory arthritis
RU2535074C2 (ru) 2009-08-28 2014-12-10 Лэйбрис Байолоджикс, Инк. Способы лечения висцеральной боли путем введения антител-антагонистов, направленных против пептида, связанного с геном кальцитонина
PT2475362T (pt) * 2009-09-10 2019-05-27 Kominox Inc Terapia especifica para celulas estaminais cancerigenas e para 0 cancro resistente a medicamentos
FR3004949B1 (fr) * 2013-04-26 2016-02-05 Centre Nat Rech Scient Traitement de maladies autoimmunes et inflammatoires par les composes de l'arsenic as203 et/ou as205 administres par voie locale
RS65360B1 (sr) 2014-03-21 2024-04-30 Teva Pharmaceuticals Int Gmbh Antagonistička antitela specifična za peptid genski srodan kalcitoninu i postupci njihove upotrebe
US10556945B2 (en) 2014-03-21 2020-02-11 Teva Pharmaceuticals International Gmbh Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
KR102015858B1 (ko) * 2015-10-23 2019-08-30 손영태 법제된 비상을 함유하는 면역력 증강을 위한 약학적 조성물
AU2017331593B2 (en) 2016-09-23 2022-04-28 Teva Pharmaceuticals International Gmbh Treating refractory migraine
KR101834366B1 (ko) * 2016-11-21 2018-03-05 주식회사 케마스 육산화사비소의 결정다형을 포함하는 유방암 예방 또는 치료용 약학 조성물 및 이의 제조방법
KR101844049B1 (ko) 2016-12-05 2018-03-30 주식회사 케마스 육산화사비소의 결정다형을 포함하는 간암 예방 또는 치료용 약학 조성물
KR101844050B1 (ko) * 2016-12-09 2018-05-14 주식회사 케마스 육산화사비소의 결정다형을 포함하는 암 예방 또는 치료용 약학 조성물
CN106890353A (zh) * 2017-03-31 2017-06-27 应剑波 一种具有抗菌滋养功能的医用辅料
US10716807B2 (en) * 2017-05-09 2020-07-21 Medsenic Method of treating relapsing-remitting multiple sclerosis using arsenic trioxide
MA52088A (fr) * 2018-03-22 2021-01-27 Komipharm Int Australia Pty Ltd Composition pharmaceutique comprenant du méta-arsénite et procédé de fabrication
RU2687599C1 (ru) * 2018-11-22 2019-05-15 Федеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования "Российская медицинская академия непрерывного профессионального образования" Министерства здравоохранения Российской Федерации (ФГБОУ ДПО РМАНПО Минздрава России) Способ лечения постмастэктомического синдрома
CN109674817B (zh) * 2019-01-31 2021-06-29 哈尔滨医科大学 三氧化二砷在制备治疗晚期动脉粥样硬化药物中的用途
CN117085038A (zh) * 2019-05-21 2023-11-21 麦德赛尼克公司 金属离子增强砷的治疗作用的用途
CN115243692A (zh) * 2020-02-16 2022-10-25 科微范国际澳大利亚私人有限公司 使用偏亚砷酸盐的治疗方法
RU2755329C2 (ru) * 2020-03-13 2021-09-15 ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ "РОССИЙСКИЙ НАУЧНЫЙ ЦЕНТР РАДИОЛОГИИ И ХИРУРГИЧЕСКИХ ТЕХНОЛОГИЙ ИМЕНИ АКАДЕМИКА А.М. ГРАНОВА" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ /ФГБУ "РНЦРХТ им. академика А.М. Гранова" Минздрава России Способ лечения нерезектабельной гилюсной холангиокарциномы
WO2021198535A1 (en) * 2020-04-03 2021-10-07 Medsenic Use of an arsenic compound for treating a short or long cytokine storm in various autoimmune/inflammatory diseases in humans or animals
EP3988093A1 (en) * 2020-10-22 2022-04-27 Medsenic Use of an arsenic compound for treating a cytokine storm
KR102240693B1 (ko) * 2020-05-18 2021-04-15 주식회사 케마스 육산화사비소를 포함하는 코로나바이러스 감염증의 예방 또는 치료용 약학조성물
KR20220020637A (ko) * 2020-08-12 2022-02-21 이상봉 항암화학요법이나 방사선요법으로 인한 암 환자의 탈모증을 포함한 탈모증 환자에 대하여 탈모를 방지하고 발모를 촉진하는 메타아르세나이트의 염을 함유하는 경구 투여용 약학적 조성물
KR20220020633A (ko) * 2020-08-12 2022-02-21 이상봉 탈모방지 또는 발모촉진용 주사제 조성물
CA3205138A1 (en) 2020-12-17 2022-06-23 Vertex Pharmaceuticals Incorporated Compositions and methods for editing beta-globin for treatment of hemaglobinopathies

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US536273A (en) * 1895-03-26 Tavus rein
US1498639A (en) * 1919-12-02 1924-06-24 David S Pratt Arsenical composition and method of making same
US3622664A (en) * 1968-11-21 1971-11-23 John A Brown Treatment of infectious keratitis in animals with sodium arsenite
SU955909A1 (ru) * 1980-06-25 1982-09-07 Центральный Ордена Ленина Институт Усовершенствования Врачей Способ профилактики осложнений при пересадке тканей
US4677974A (en) * 1985-09-30 1987-07-07 David Leonardi Method and apparatus for immobilizing an eyelid
CA2051012C (en) 1990-09-14 2002-04-02 David R. Borcherding Carbocyclic adenosine analogs useful as immunosupressants
ITTO930510A1 (it) 1993-07-09 1993-10-07 Walter Tarello Farmaci attivi contro la chronic fatigue syndrome (c.f.s.)
US5889048A (en) 1994-02-18 1999-03-30 Vorobieva; Tamara Vasilievna Methods and compositions for treating defective cell functions
US5362735A (en) * 1994-02-23 1994-11-08 Smithkline Beecham Corporation Rapamycin derivatives
IT1272994B (it) * 1994-05-25 1997-07-01 Giampiero Valletta Uso di prodotti contenenti magnesio nella terapia e nella profilassi di malattie neoplastiche e di malattie di tipo autoimmunitario.-
IT1295067B1 (it) * 1997-09-25 1999-04-27 Walter Tarello Uso di arsenico per preparare un medicamento per il trattamento della sindrome premestruale
DE69840057D1 (de) 1997-10-15 2008-11-06 Polarx Biopharmaceuticals Inc Pharmazeutische Zusammensetzungen enthaltend Arsentrioxid zur Behandlung von Krebs des zentralen Nervensystems
KR20020083678A (ko) * 2001-04-28 2002-11-04 주식회사 한국미생물연구소 아르세닉산나트륨 염, 소디움 메타아르세나이트 또는 이의혼합물을 함유한 항암제 조성물
TW200408407A (en) 2001-11-30 2004-06-01 Dana Farber Cancer Inst Inc Methods and compositions for modulating the immune system and uses thereof
TWI259079B (en) * 2002-02-08 2006-08-01 Merck & Co Inc N-biphenyl(substituted methyl)aminocycloalkanecarboxamide derivatives
EP2042182B1 (en) 2002-04-10 2013-05-22 Komipharm International Co., Ltd. Pharmaceutical composition comprising arsenite for the treatment of malignancy
RU2310460C2 (ru) * 2002-04-10 2007-11-20 Корея Микробиолоджикал Лабораторис, Лтд. Фармацевтическая композиция для лечения злокачественной опухоли, содержащая арсенит натрия
FR2838965B1 (fr) 2002-04-26 2004-06-25 Centre Nat Rech Scient Therapie par l'arsenic du syndrome autoimmunlymphoproliferatif de type apls chez la souris comme chez l'homme
JP2005206591A (ja) * 2003-12-25 2005-08-04 Mitsubishi Pharma Corp 神経因性疼痛の予防及び／又は治療のための医薬
WO2006069293A2 (en) * 2004-12-22 2006-06-29 Friedman Robert S Composition comprising n-acetylcysteine and further pain or anti- inflamm medications
JP2006206461A (ja) 2005-01-26 2006-08-10 Teizo Chinen アレルギー疾患の予防・治療用組成物
WO2006104292A1 (en) * 2005-03-31 2006-10-05 Komipharm International Co., Ltd. Pharmaceutical composition comprising arsenic acid, meta-arsenite, and pharmaceutically acceptable salts
EP1721615A1 (en) 2005-05-09 2006-11-15 Komipharm International Co., Ltd. Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis
US20060292243A1 (en) 2005-06-24 2006-12-28 Shao-Chi Hsin Arsenic compounds for the treatment of the arsenic-sensitive blast-cell related diseases

Similar Documents

Publication Publication Date Title
JP2013147511A5 (enExample)
Prantera et al. Rifaximin-extended intestinal release induces remission in patients with moderately active Crohn's disease
JP2018193377A5 (enExample)
Cassinotti et al. Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn’s disease
JP2013505205A5 (enExample)
Mevorach et al. Single infusion of donor mononuclear early apoptotic cells as prophylaxis for graft-versus-host disease in myeloablative HLA-matched allogeneic bone marrow transplantation: a phase I/IIa clinical trial
JP2011520911A5 (enExample)
JP2015505564A5 (enExample)
JP2013231087A5 (enExample)
JP2015038135A5 (enExample)
JP2018513188A5 (enExample)
JP2020522549A5 (enExample)
RU2016132762A (ru) Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением
JP2015508765A5 (enExample)
JP2016505561A5 (enExample)
JP2013501049A5 (enExample)
MX2020010738A (es) Formulaciones de ciclosporina para uso en el tratamiento del sindrome de bronquiolitis obliterante (bos).
JP2016505050A5 (enExample)
MX391602B (es) Composicion farmaceutica con antagonista del receptor de mineralocorticoides y su uso
JP2016528171A5 (enExample)
JP2019535830A5 (enExample)
Song et al. Autologous stem cell transplantation for systemic lupus erythematosus: report of efficacy and safety at 7 years of follow-up in 17 patients
JP2010538054A5 (enExample)
FI3359572T3 (fi) Menetelmä multippeliskleroosin hoitamiseksi
Yu et al. Ultrasound-guided percutaneous portal transplantation of peripheral blood monocytes in patients with liver cirrhosis